Answers are grounded in this paper and cite their sources.
Two undescribed flavonoid glycosides, (2 R,3R)-dihydrokaempferol 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside (1) and 5,7,4′-trimethoxyflavone 3-O-β-D-xylopyranosyl-(1→2)-β-D-glucopyranoside (2), two undescribed monoacylglucosylglycerols, (2S)-1-O-(6-deoxy-6-sulfo)-α-D-glucopyranosyl-3-O-linolenoyl glyceride (3) and (2S)-1-O-(6-deoxy-6-sulfo)-α-D-glucopyranosyl-3-O-oleoyl glyceride (4), together with five known compounds, gingerglycolipid B (5), 3-O-neohesperidosyl-7-O-rhamnosylkaempferol (6), 3-O-glucosyl-7-O-rhamnosylkaempferol (7), kaempferitrin (8), and 7-O-glucosylapigenin (9) were isolated from the leaves of Ligustrum sinense. Structural elucidation of 1–9 was achieved using 1H,13C NMR, COSY, HSQC, and HMBC experiments, in conjunction with HRESIMS data. The absolute configuration of 2 was deduced by ECD spectrum. Flavonoids (1,2, 6–9) inhibited xanthine oxidase activity with IC50 values ranging from 11.6 to 58.4 μM. Meanwhile, monoacylglycosylglycerols 3–5 were inactivity (IC50 > 100 μM).
No takes yet. Share an insight, caveat, or question.
Nga et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: